60 Degrees Pharmaceuticals, Inc. (SXTP): Total Assets
$5.37M
As of 2025-12-31
$4.28M
As of 2026-06-30
+60.5%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.37M | -6.8% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $5.76M | -26.0% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $7.78M | +500.0% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $1.30M | n/a | 2024-04-01, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $91.03M | 0.0% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $32.47M | +46.9% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $114.11M | +17.8% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $359.1K | +1.3% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $34.75M | +60.4% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $28.71M | +0.4% |
| Rallybio Corp (RLYB) | 2025-12-31 | $62.26M | -8.6% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
Compare SXTP, STTK, DARE, RFL side by side · Screen every company in Pharmaceutical Preparations ↗